Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
This study is enrolling participants by invitation only.
University of Witwatersrand, South Africa
First Posted: August 23, 2013
Last Update Posted: May 13, 2016
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Cynthia S Firnhaber, University of Witwatersrand, South Africa
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||March 2017|
|Estimated Primary Completion Date:||December 2016 (Final data collection date for primary outcome measure)|